AtaiBeckley (ATAI) Debt Ratio (2021 - 2026)

AtaiBeckley (ATAI) recorded quarterly Debt Ratio of 0.0 in Q1 2026, up 26.42% quarter-over-quarter from 0.0 in Q4 2025.

AtaiBeckley (ATAI) Debt Ratio (2021 - 2026) Analysis & Trends

AtaiBeckley's Debt Ratio history runs 3 years deep, the most recent figure standing at 0.0 for Q1 2026.

  • In Q1 2026, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (changed N/A YoY), while the FY2025 annual figure was 0.0, down 97.68% from the prior year.
  • Debt Ratio was 0.0 for Q1 2026 at AtaiBeckley, up from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.43 in Q3 2023 to a low of 0.0 in Q2 2021.
  • The 5-year median for Debt Ratio is 0.0 (2022), against an average of 0.06.
  • Biggest YoY gain for Debt Ratio was 97.68% in 2025; the steepest drop was 97.68% in 2025.
  • A 3-year view of Debt Ratio shows it stood at 0.04 in 2024, then slumped by 97.68% to 0.0 in 2025, then advanced by 26.42% to 0.0 in 2026.
  • The last three Debt Ratio figures came in at 0.0 (Q1 2026), 0.0 (Q4 2025), and 0.04 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.18
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 AtaiBeckley 1.45 Bn 1.45 Bn - 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Mar 31, 2025 0.06
Dec 31, 2024 0.00
Dec 31, 2024 0.04
Mar 31, 2024 0.00
Sep 30, 2023 0.43
Dec 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00